Literature DB >> 10887492

Growth factor and sex steroid interactions in breast cancer.

N J Kenney1, R B Dickson.   

Abstract

Mitogenic and inhibitory growth factors and steroid ovarian hormones play important roles as selective modulators of normal mammary development and in the onset and the progression of human breast cancer. The focus of this article is to review past and current research on the interactions of these two classes of effectors in mammary gland development and neoplasia. Steroid hormones regulate synthesis of growth stimulatory and inhibitory growth factors, growth factor receptors, and growth factor binding proteins. In turn, growth factor pathways may modulate phosphorylation and function of steroid receptors and potentiate or inhibit the mitogenic actions of steroids. Ultimately, during the progression of the malignant mammary epithelial cell to hormonal autonomy, overexpression, mutation, or disregulation of key elements of growth factor signal transduction pathways all may play critical roles.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 10887492     DOI: 10.1007/BF02013642

Source DB:  PubMed          Journal:  J Mammary Gland Biol Neoplasia        ISSN: 1083-3021            Impact factor:   2.673


  71 in total

1.  Progestins both stimulate and inhibit breast cancer cell cycle progression while increasing expression of transforming growth factor alpha, epidermal growth factor receptor, c-fos, and c-myc genes.

Authors:  E A Musgrove; C S Lee; R L Sutherland
Journal:  Mol Cell Biol       Date:  1991-10       Impact factor: 4.272

2.  Transforming growth factor activity in pleural and peritoneal effusions from cancer and non-cancer patients.

Authors:  M Sairenji; K Suzuki; K Murakami; H Motohashi; T Okamoto; M Umeda
Journal:  Jpn J Cancer Res       Date:  1987-08

3.  Identification and regulation of insulin-like growth factor binding proteins produced by hormone-dependent and -independent human breast cancer cell lines.

Authors:  I Kim; A Manni; J Lynch; J M Hammond
Journal:  Mol Cell Endocrinol       Date:  1991-06       Impact factor: 4.102

Review 4.  Protein kinase C isozymes and substrates in mammary carcinogenesis.

Authors:  S C Kiley; J Welsh; C J Narvaez; S Jaken
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-04       Impact factor: 2.673

Review 5.  The type 1 (EGFR-related) family of growth factor receptors and their ligands.

Authors:  S A Prigent; N R Lemoine
Journal:  Prog Growth Factor Res       Date:  1992

6.  Differential regulation of expression of three transforming growth factor beta species in human breast cancer cell lines by estradiol.

Authors:  B A Arrick; M Korc; R Derynck
Journal:  Cancer Res       Date:  1990-01-15       Impact factor: 12.701

7.  Urinary TGFs1 in neoplasia: immunoreactive TGF-alpha in the urine of patients with disseminated breast carcinoma.

Authors:  K Stromberg; W R Hudgins; D N Orth
Journal:  Biochem Biophys Res Commun       Date:  1987-04-29       Impact factor: 3.575

8.  Transforming growth factor-alpha promotes mammary tumorigenesis through selective survival and growth of secretory epithelial cells.

Authors:  G H Smith; R Sharp; E C Kordon; C Jhappan; G Merlino
Journal:  Am J Pathol       Date:  1995-10       Impact factor: 4.307

9.  Immunohistochemical staining for transforming growth factor beta 1 associates with disease progression in human breast cancer.

Authors:  S M Gorsch; V A Memoli; T A Stukel; L I Gold; B A Arrick
Journal:  Cancer Res       Date:  1992-12-15       Impact factor: 12.701

10.  Identification and biological characterization of an epidermal growth factor-related protein: cripto-1.

Authors:  R Brandt; N Normanno; W J Gullick; J H Lin; R Harkins; D Schneider; B W Jones; F Ciardiello; M G Persico; F Armenante
Journal:  J Biol Chem       Date:  1994-06-24       Impact factor: 5.157

View more
  12 in total

Review 1.  Tissue architecture and breast cancer: the role of extracellular matrix and steroid hormones.

Authors:  R K Hansen; M J Bissell
Journal:  Endocr Relat Cancer       Date:  2000-06       Impact factor: 5.678

Review 2.  Mammary gland development and tumorigenesis in estrogen receptor knockout mice.

Authors:  W P Bocchinfuso; K S Korach
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-10       Impact factor: 2.673

3.  Overexpression of insulin-like growth factor II (IGFII) in ZR-75-1 human breast cancer cells: higher threshold levels of receptor (IGFIR) are required for a proliferative response than for effects on specific gene expression.

Authors:  K Abdul-Wahab; D Corcoran; A Perachiotti; P D Darbre
Journal:  Cell Prolif       Date:  1999-10       Impact factor: 6.831

Review 4.  Growth factors, apoptosis, and survival of mammary epithelial cells.

Authors:  E C Rosfjord; R B Dickson
Journal:  J Mammary Gland Biol Neoplasia       Date:  1999-04       Impact factor: 2.673

Review 5.  Use of the autopsy to study ontogeny and expression of the estrogen receptor gene in human breast.

Authors:  S A Bartow
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-01       Impact factor: 2.673

Review 6.  ErbB2 activation and signal transduction in normal and malignant mammary cells.

Authors:  N E Hynes
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-04       Impact factor: 2.673

Review 7.  Protein kinase C isozymes and substrates in mammary carcinogenesis.

Authors:  S C Kiley; J Welsh; C J Narvaez; S Jaken
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-04       Impact factor: 2.673

8.  Gαo potentiates estrogen receptor α activity via the ERK signaling pathway.

Authors:  Melyssa R Bratton; James W Antoon; Bich N Duong; Daniel E Frigo; Syreeta Tilghman; Bridgette M Collins-Burow; Steven Elliott; Yan Tang; Lilia I Melnik; Ling Lai; Jawed Alam; Barbara S Beckman; Steven M Hill; Brian G Rowan; John A McLachlan; Matthew E Burow
Journal:  J Endocrinol       Date:  2012-05-04       Impact factor: 4.286

Review 9.  Reciprocal regulation of extracellular matrix proteins and ovarian steroid activity in the mammary gland.

Authors:  S Z Haslam; T L Woodward
Journal:  Breast Cancer Res       Date:  2001-08-02       Impact factor: 6.466

10.  Identification of Stem Cell Units in the Terminal End Bud and Duct of the Mouse Mammary Gland.

Authors:  Nicholas J. Kenney; Gilbert H. Smith; Erin Lawrence; J. Carl Barrett; David S. Salomon
Journal:  J Biomed Biotechnol       Date:  2001
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.